INZY — Inozyme Pharma Share News
0.000.00%
Last trade - 00:00- $257.60m
- $219.11m
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin
U.S. STOCKS ON THE MOVE-Estee Lauder, Charter Communications, Vistra
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin
Brief: Biomarin To Acquire Inozyme Pharma
Inozyme Pharma Inc reports results for the quarter ended March 31 - Earnings Summary
Inozyme Pharma Inc expected to post a loss of 41 cents a share - Earnings Preview
Inozyme Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Inozyme Pharma Inc expected to post a loss of 41 cents a share - Earnings Preview
Brief: Inozyme Pharma Reports Positive Interim Data For INZ-701 And Key Program Updates
U.S. RESEARCH ROUNDUP-Apollo, Booking Holdings, Portillos
Inozyme Pharma Inc reports results for the quarter ended in September 30 - Earnings Summary
Inozyme Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Inozyme Pharma Announces Positive Interim Data From Phase 1 Seaport 1 Trial Of Inz-701
Brief: Inozyme Pharma Announces Presentation Of Interim Data From Phase 1 Seaport 1 Trial At The Upcoming American Society Of Nephrology (ASN) Kidney Week 2024
Inozyme Pharma Inc reports results for the quarter ended in January - Earnings Summary
Inozyme Pharma Inc expected to post a loss of 39 cents a share - Earnings Preview